Top stock upgrades today in the BUZZ

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  10 Mar 2026
 

$ACHR saw a boost as Needham maintained a Buy rating despite lowering the price target to $9. Investors reacted positively to the confidence in Archer Aviation growth potential, with upside expectations near 77% from current levels signaling strong speculative interest.

$APLS gained attention after JPMorgan reaffirmed an Overweight stance. The combination of solid pipeline developments and robust biotech sentiment helped push the shares higher, supporting near-term momentum and keeping them on traders’ radars.

$ASML rose following a price target lift from BofA to $1886. Tight supply conditions in Foundry and DRAM markets underpin the bullish case, while ongoing demand for advanced lithography solutions justifies the sustained institutional interest.

$CAVA started coverage with an Outperform recommendation by Wolfe Research. Analysts see long-term expansion potential in the fast-casual segment, even if near-term downside of 7.5% is factored in, giving traders a cautiously bullish entry point.

$CFG climbed as Baird upgraded the stock to Outperform from Neutral. With modest upside of just over 2%, the upgrade reflects improving fundamentals and confidence in Citizens Financial Group execution rather than a dramatic near-term catalyst.

$DNN jumped on a price target raise to C$7 at Desjardins, reflecting positive sentiment around uranium development prospects. The 73% upside suggests a significant trading opportunity for speculative investors focused on energy transition metals.

$FCX rallied after an upgrade to Buy, with copper outlook improving. Despite current prices above the new target, the upgrade signals confidence in Freeport-McMoRan ability to capitalize on commodity cycles.

$FTRE saw a strong move after TD Cowen upgraded to Buy. With projected upside exceeding 100%, Fortrea Holdings stands out as a high-risk, high-reward candidate for traders seeking leveraged opportunities in the industrial sector.

$GEV benefited from Rothschild & Co moving the rating to Buy from Sell. The modest upside of less than 1% reflects a stabilization story rather than a dramatic growth play, appealing more to conservative investors.

$GRMN held steady on analyst support despite broader market turbulence. The rating reaffirms Garmin role as a resilient tech play amid geopolitical risk factors impacting commodities and energy sectors.

$HBM jumped after S&P Global upgraded on strong cash flow. The 68% upside suggests both operational efficiency and investor appetite for mining exposure are driving price action.

$HIMS rose following Needham upgrade to Buy. With potential upside above 100%, Hims & Hers Health appeals to traders targeting rapid growth in telehealth and consumer wellness.

$HTHT climbed as UBS upgraded to Buy, reflecting modest upside and positive sentiment toward hospitality recovery trends.

$IQV gained following TD Cowen upgrade to Buy. The 37% upside points to optimism around healthcare analytics growth, attracting institutional buying.

$ITT saw a positive response after Barclays initiated coverage with an Equal-Weight recommendation. The upside of nearly 10% makes it a steady play with measured risk.

$MA strengthened as BofA reinstated coverage with a Buy rating. The 30% potential upside underlines confidence in long-term payment volume growth and fintech adoption.

$NU moved higher after Morgan Stanley raised the price target to $21 and reiterated Overweight. With upside above 13%, it offers a moderate growth opportunity for investors tracking Latin American fintech adoption.

$PINS saw limited upside as Rosenblatt maintained Buy with a $20 target. While upside is slightly negative vs. current price, analyst reaffirmation keeps sentiment supported in a weak software market.

$PLD gained modestly on Citi reinstated Buy coverage. The 2% upside reflects steady REIT fundamentals and institutional confidence rather than speculative excitement.

$PLUG drifted slightly lower despite maintaining a Buy rating. The lowered price target tempers upside to 33%, but speculative traders may still find value in its renewable energy exposure.

$RJF lifted Algonquin Power & Utilities after Raymond James upgraded to Outperform. The 21% upside makes it appealing for dividend-focused investors seeking utility exposure.

$SG rose modestly after Wolfe Research initiated coverage with Peer Perform. Upside of 13% points to cautious optimism in the fast-casual sector.

$SHAK jumped on Wolfe Research initiating coverage with Outperform. With 19% upside, Shake Shack remains a compelling consumer discretionary name for near-term trades.

$SLNO gained slightly after H.C. Wainwright maintained a Buy rating. The small 5% upside suggests more measured interest for traders focused on biotech small-caps.

$SSRM rallied after BMO upgraded following the $1.5B Çöpler Mine sale. The move highlights strong operational execution and near-term cash flow improvements.

$TDOC advanced on Deutsche Bank upgrade reflecting confidence in BetterHelp strategy execution. The 61% upside signals strong potential for growth in telehealth services.

$TEX rose after Citigroup upgraded from Neutral to Buy. With 26% upside, Terex offers a solid industrial play as construction demand picks up.

$TFC climbed on Baird upgrade to Outperform. The 28% upside positions Truist Financial as an attractive near-term trade in regional banking.

$WAL gained on Wells Fargo upgrade. With nearly 43% upside, Western Alliance Bancorporation stands out among regional banks for near-term opportunity.

$WING advanced following Wolfe Research initiating coverage with Outperform. The 49% upside makes Wingstop a high-potential consumer discretionary candidate for traders seeking a strong play on brand expansion.

$XPRO slipped slightly after a downgrade to Sell, signaling limited near-term opportunity despite minor price movement.

View All Headlines